AZ6102 |
AZ6102 : NAD+ competitive inhibitor of TNKS, TNKS2
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| TNKS |
|
|
| TNKS2 |
|
|
NAD+ competitive
50-500 nM
Selectivity
In Vitro Selectivity Assessment
Potency: IC50 - PARP1 2 uM, PARP2 0.5 uM, PARP6 >5 uM
Potency Assay Off-Target:
SPA or BPS PARP assay kit. In in vitro ADP ribosylation assays, AZ-6102 was selective for TNKS1/2 ov ...
Selectivity Assessment Description:
SPA or BPS PARP assay kit. In in vitro ADP ribosylation assays, AZ-6102 was selective for TNKS1/2 ov ...
Potency Cellular
In Vitro
TNKS
Mode of Action: NAD+ competitive
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/acs.jmedchem.6b00990
TNKS2
Mode of Action: NAD+ competitive
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/acs.jmedchem.6b00990
In Vivo Validations
Rat, Mouse
Dose: 25 mg/kg IV (mouse)
Route of delivery:
Intravenous, Oral
Plasma half life:
5.7 hr (rat IV), 4.3 hr (mouse IV)
Systemic clearance:
11 mL/min•kg (rat IV), 24 mL/min•kg (mouse IV)
DOI Reference: 10.1021/acs.jmedchem.6b00990
Chemical Information
| Molecular Formula | C25H28N6O |
| SMILEs | Cc1cc(N2C[C@H](C)N[C@H](C)C2)ncc1-c1ccc(-c2nc(=O)c3ccn(C)c3[nH]2)cc1 |
| InChI | InChI=1S/C25H28N6O/c1-15-11-22(31-13-16(2)27-17(3)14-31)26-12-21(15)18-5-7-19(8-6-18)23-28-24-20(25(32)29-23)9-10-30(24)4/h5-12,16-17,27H,13-14H2,1-4H3,(H,28,29,32)/t16-,17+ |
| Molecular weight | 428.23 Da |
| AlogP | 3.4856200000000017 |
| HBond acceptors | 7 |
| HBond donors | 2 |
| Atoms | 60 |
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.